School of Medicine

The American Academy of Neurology has honored him with the Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases.

During last year’s Komen St. Louis Race for the Cure, the Siteman Cancer Center fielded the event’s third-largest team.

Applicants from the basic sciences, epidemiological and behavioral science departments are especially encouraged to apply.

When he was young, Bruce D. Lindsay, M.D., associate professor of medicine, liked to wrestle. Back then, his opponents were scrappy kids from Haddonfield, N. J., bent on proving their worth. Today, the stakes are higher for Lindsay, but the characteristics of a good wrestler — intelligence, action and especially perseverance — are clear in […]

Chemistry Professor Karen L. Wooley is principal investigator of a program that has received funding of $12.5 million for five years.

The National Heart, Lung, and Blood Institute has chosen the School of Medicine as one of four national research centers dedicated to the advancement of nanotechnology. The center, funded by a five-year, $12.5 grant, will be headed by WUSM chemist Karen Wooley. Read more in the following St. Louis Post-Dispatch article.

Area adults and children can find out if symptoms such as a chronic cough, wheezing and shortness of breath might be a sign of asthma through Washington University’s participation in the ninth annual Nationwide Asthma Screening Program.

Washington University in St. Louis has been chosen as a Program of Excellence in Nanotechnology (PEN) by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. Karen Wooley, Ph.D., Washington University professor of chemistry in Arts & Sciences, is principal investigator of the Program, which NHLBI is funding at $12.5 million for five years.

MorrisThe American Academy of Neurology has awarded the 2005 Potamkin Prize for Research in Pick’s, Alzheimer’s and Related Diseases to John C. Morris, M.D., the Friedman Distinguished Professor of Neurology and director of the Alzheimer’s Disease Research Center (ADRC) at the School of Medicine.

Theodore J. Cicero, Ph.D., vice chancellor for research, plans to step down in June 2006 after 10 years of leading the University’s research enterprise. Before his appointment as the head of research for the University, Cicero served as vice chairman for research in the Department of Psychiatry. He will return to that position and devote more time to his own research.